more attention focused on urinary incontinence
February 1999
You'll see more attention focused on urinary incontinence.
This is a big problem. More than 15 million people suffer from bladder problems...only about 10% seek help.
This attention is partly fueled by ads for two new drugs...Ditropan XL (oxybutynin) and Detrol (tolterodine). These drugs inhibit bladder contractions and delay the desire to void.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote